Qube Research & Technologies LTD Arcutis Biotherapeutics, Inc. Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$8.32 - $11.0 $169,994 - $224,752	20,432 New	20,432 $190,000
Q4 2023 Feb 13, 2024	BUY	$1.84 - $4.82 $1.34 Million - $3.5 Million	725,894 New	725,894 $2.34 Million
Q2 2023 Aug 14, 2023	SELL	$7.51 - $15.0 $51,826 - $103,515	-6,901 Reduced 33.61%	13,631 $129,000
Q1 2023 May 15, 2023	SELL	$10.23 - $17.14 $386,202 - $647,069	-37,752 Reduced 64.77%	20,532 $225,000
Q4 2022 Feb 14, 2023	BUY	$13.96 - $20.4 $813,644 - $1.19 Million	58,284 New	58,284 $862,000

218

129M

2.02M

202K

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $784M
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.